Insulin sensitizing drugs

Abstract

Metformin as the basic oral antidiabetic agent and thiazolidinediones rosiglitazone and pioglitazone in Type 2 diabetes therapy. The future of PPAR sensitizing drugs.

Keywords

• metformin
• rosiglitazone
• pioglitazone
• PPAR sensitizers
• selective PPAR modulators
• panPPAR sensitizers